Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

HYFT

Strong SellSinker

MindWalk Holdings Corp. · Healthcare · United States · $65M · Avg Vol: $161K/d

14
StockRank
Get insider-trade alerts
Q
33
V
25
M
35
P/E (TTM)
ROE
-85.4%
D/E
0.3x
Dividend %

COMPANY DESCRIPTION

MindWalk Holdings Corp. operates as a bio-native AI company. It focuses on the integration of artificial intelligence, multi-omics data, and advanced laboratory research to accelerate the discovery and development of biologics.

FINANCIAL SUMMARY (USD)

Year2023202420252026CAGRTTM2027E2028EFwd CAGR
Revenue14.9M7.4M7.7M11.2M-9.0%11.3M14.6M18.0M26.5%
EPS-0.77-0.74-0.65-0.22-0.24-0.16-0.12
Shares25.1M26.9M46.2M46.7M+86.5%47.0M
Debt5.2M9.9M9.7M2.5M-21.4%2.6M
Equity41.7M25.7M17.0M8.5M-41.2%
Op CF-14.3M-2.3M-4.6M-9.0M-9.0M
Inv CF-1.4M-1.1M-0.6M9.8M
Fin CF-0.4M0.7M10.7M83.0K
Loading 1Y...
PRICE (1Y)-2.2%
1.281.321.371.411.45Jul 30Aug 20Sep 10
SMA 50SMA 200

Close
$1.32
RSI (14)
44.0
52W High
$2.99
From 52W High
0.4%

SCORE BREAKDOWN

Quality
33
ROIC (ROA)
-28.4%*25.6
ROE
-85.4%11.3
GP/Assets
20.1%44.9
Op. Margin
-105.2%16.7
FCF/Assets
-26.9%15.9
Piotroski
668.7
Int. Cover
N/A
D/E Ratio
0.30x40.9
Current Ratio
2.80x52.2
Value
25
P/E (TTM)
N/A
EV/EBITDA
-5.6x25.0
P/FCF
N/A
P/B
10.0x12.0
P/S
5.5x39.3
Div Yield
N/A
Momentum
35
52W High %
44%17.8
RS 6M
-10%56.0
SMA 50/200
0.92x36.2
EPS Rev 4W
N/A
EPS Rev 12W
N/A
EPS Improve
N/A
Q Growth
N/A

FUNDAMENTALS

Market Cap
$65M
P/E (Forward)
Gross Margin
58.8%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of HYFT are excluded.

TickerCompanyMkt CapStockRankSignal
HYFTMindWalk Holdings Corp.(you)$65M14Strong Sell
SERSerina Therapeutics, Inc.$62M14Strong Sell
PLRXPliant Therapeutics, Inc.$69M12Strong Sell
IMAImageneBio, Inc.$61M15Strong Sell
INKTMiNK Therapeutics, Inc.$58M15Strong Sell
TELOTelomir Pharmaceuticals, Inc.$78M13Strong Sell
ANVSAnnovis Bio, Inc.$73M12Strong Sell
OSTXOS Therapies Incorporated$76M15Strong Sell
PMVPPMV Pharmaceuticals, Inc.$65M19Strong Sell
4875.TMediciNova, Inc.$70M18Strong Sell

Peer medians: ROE -30.2% · P/E 27.0x · Gross margin 58.1%

MindWalk Holdings Corp. (HYFT): Stock Score Summary

MindWalk Holdings Corp. (HYFT) has a MoatMap StockRank of 14/100 based on Quality (33/100), Value (25/100), and Momentum (35/100) factor scores. The current signal is STRONG SELL.

MindWalk Holdings Corp. operates as a bio-native AI company. It focuses on the integration of artificial intelligence, multi-omics data, and advanced laboratory research to accelerate the discovery and development of biologics.

Key Financial Metrics

Price$1.32
Market Cap$65M
Price/Book10.01
Return on Equity-85.4%
Debt/Equity0.30x
Gross Margin58.8%
Operating Margin-105.2%
Revenue Growth49.8%
Free Cash Flow$-9M

MindWalk Holdings Corp. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is MindWalk Holdings Corp.’s (HYFT) StockRank?
MoatMap’s StockRank for MindWalk Holdings Corp. (HYFT) is 14/100, with a Strong Sell signal. It is a composite of Quality (33), Value (25), and Momentum (35) factor ranks across MoatMap’s universe of 25,000+ stocks.
Does MindWalk Holdings Corp. have an economic moat?
MindWalk Holdings Corp. (HYFT) has a Quality factor score of 33/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage: the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is MindWalk Holdings Corp. a buy, hold, or sell?
MoatMap’s current signal for MindWalk Holdings Corp. (HYFT) is Strong Sell, based on a StockRank of 14/100. Signals are derived mechanically from the StockRank composite and should be one input among many; combine with your own thesis on management, competitive position, and valuation.
What sector is MindWalk Holdings Corp. in?
MindWalk Holdings Corp. (HYFT) operates in the Healthcare sector, specifically the Biotechnology industry (United States).